What it is
Dihexa is a small synthetic compound derived from angiotensin IV. It has been studied in laboratory models for its interaction with the hepatocyte growth factor (HGF) / c-Met signaling system.
What the research says
- Published work describes angiotensin IV-derived compounds, including dihexa, acting through the HGF/c-Met system in laboratory and animal experiments [1].
- We did not find published human clinical trials of dihexa.
Regulatory status
Dihexa is research-stage (preclinical). It is not FDA approved for any use, and compounded versions are not FDA approved. Where prescribed, compounded versions are prepared by state-licensed 503A compounding pharmacies.
Safety and side effects
We did not find human safety data for dihexa. Because it acts on a growth-factor pathway and human data are lacking, side effects in people are unknown. A licensed healthcare provider should review your complete history before deciding whether anything is appropriate.
Is it right for you?
Only a licensed healthcare provider can decide whether any treatment is appropriate for you.
Frequently asked questions
Has dihexa been studied in people?
We did not find human clinical trials. Published research is preclinical [1].
Is dihexa approved by FDA?
No. Dihexa is not FDA approved and is research-stage. Compounded versions are not FDA approved.
Do I need a prescription for Dihexa?
Yes. Prescription only, requires evaluation by a licensed provider. A provider decides whether it is appropriate for you.
Sources
- McCoy AT, et al. J Pharmacol Exp Ther, 2013 (angiotensin IV analog study in animal models; PubMed 23055539). https://pubmed.ncbi.nlm.nih.gov/23055539/
Dihexa content on this page is for education. Compounded medications are not FDA approved. Prescription only, requires evaluation by a licensed provider. Educational content only, not medical advice.